ArticleFrontiers in cardiovascular medicine2025
Case Report: Three cases of drug-coated balloon-only strategy for coronary artery lesions with aneurysms in the chronic phase.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Coronary aneurysms are rare; therefore, treatment strategies for coronary lesions with aneurysms remain elusive. We describe three cases of coronary artery lesions with aneurysms in patients treated with drug-coated balloons (DCBs). Case description: Case 1 had ST-segment elevation myocardial infarction with a right coronary artery aneurysm treated with a paclitaxel DCB. Case 2 had stenoses of the left anterior descending artery and diagonal branch, along with a coronary aneurysm treated using paclitaxel DCBs. Case 3 had a calcified left anterior descending artery with an aneurysm treated using a paclitaxel DCB. The acute outcomes of these cases were favorable, and prognoses based on follow-up computed tomography angiography findings in the chronic phase were also favorable. Conclusion: DCBs may be one option for treating coronary artery stenosis or occlusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.